NSE: FORTIS | BSE: 532843

Download real time

949.80 -6.80 (-0.71%)

Near 52W High of ₹971.00

1.4M NSE+BSE Volume

NSE 04 Sep, 2025 3:31 PM (IST)

71,705.9

Market Cap

High in industry

0.8

Beta 1Year

Very Low volatility

Fortis Healthcare Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for FORTIS, BSE:532843 Fortis Healthcare Ltd.

Fortis Healthcare Ltd.

27 May 2022

949.80

-0.71%

FORTIS HEALTHCARE LT

Buy: Fortis Healthcare Ltd.

Prabhudas Lilladhar

Fortis Healthcare Ltd. has an average target of 982.67 from 3 brokers.

Fortis Healthcare Ltd.

01 Dec 2021

949.80

-0.71%

Ashika - Stock Picks - Fortis Healthcare Ltd. - December 2021

Buy: Fortis Healthcare Ltd.

Ashika Research

points. FHL has a long and established track record having favourable hospital maturity mix profile with large network of healthcare facilities. It has presence across various healthcare verticals, including secondary, tertiary care and diagnostics. Fortis has operations in India, United Arab Emirates (UAE) & Sri Lanka. With its...

Fortis Healthcare Ltd. has gained 30.17% in the last 3 Months

Fortis Healthcare Ltd.

01 Nov 2019

949.80

-0.71%

FORTIS HEALTHCARE LTD

Buy: Fortis Healthcare Ltd.

Ventura

Large hospital chain at a significant discount to market leader Apollo Hospitals

Fortis Healthcare Ltd. has an average target of 982.67 from 3 brokers.

Fortis Healthcare Ltd.

02 Apr 2018

949.80

-0.71%

Light House - A Quick Perspective - Fortis Healthcare Ltd. - 2 April 2018

Fortis Healthcare Ltd.

Way2Wealth

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise of hospitals, diagnostics and day care specialty facilities. Currently, the company...

Fortis Healthcare Ltd. has gained 50.98% in the last 6 Months

Fortis Healthcare Ltd.

16 Mar 2018

949.80

-0.71%

Fortis Healthcare

Buy: Fortis Healthcare Ltd.

ICICI Securities Limited

Number of FII/FPI investors increased from 452 to 512 in Jun 2025 qtr.

Fortis Healthcare Ltd.

01 Mar 2018

949.80

-0.71%

Fortis Healthcare : 2Q in-line, but a miss in 3Q; Entry of third-party key for re-rating

Buy: Fortis Healthcare Ltd.

Motilal Oswal

Fortis Healthcare (FORH) reported 2QFY18/3QFY18 revenue of INR12b (flat YoY)/INR11.2b (-1.1% YoY), with EBIDTA margin of 8.9%/4.6%. Hospital business revenue came in at INR9.7b (-0.6% YoY)/INR9b (-0.9% YoY) for2QFY18/3QFY18, with EBITDA margin of 8.5%/5.5%. SRL reported revenue ofINR2.2b (+5.2% YoY)/INR2.1b (+10% YoY), with EBITDA margin of 23.2%/18.4%.2Q numbers were in line, but 3Q numbers missed our expectations. FORH reported a loss of INR236m/INR191m in 2Q/3QFY18.

Fortis Healthcare Ltd. has gained 50.98% in the last 6 Months

Fortis Healthcare Ltd.

31 Jan 2018

949.80

-0.71%

FORTIS HEALTHCARE LIMITED

Buy: Fortis Healthcare Ltd.

Geojit Research

...

Fortis Healthcare Ltd. is trading above all available SMAs

Fortis Healthcare Ltd.

15 Nov 2017

949.80

-0.71%

Fortis Healthcare: RHT assets buyback to be value-accretive

Buy: Fortis Healthcare Ltd.

Target

Motilal Oswal

Fortis (FORH) plans to acquire all the assets of RHT for INR46.5b. Net outflow for the company will be ~INR36b, as it owns ~30% stake in RHT (worth ~INR10-10.5b). RHT asset acquisition is expected to be value-accretive to the tune of ~INR3040/share. We maintain our Buy rating on FORH, with an SOTP-based TP of INR185/share. The court case between promoters and Daichi remains a key overhang on the stock. FORH has announced that it plans to acquire the entire portfolio of assets of Religare Health Trust (RHT), listed in Singapore, at an enterprise value of INR46.5b (including debt of INR11.52b). FORH and RHT have entered into an...

Fortis Healthcare Ltd. has an average target of 982.67 from 3 brokers.

Fortis Healthcare Ltd.

09 Aug 2017

949.80

-0.71%

Result Update - Fortis Healthcare

Buy: Fortis Healthcare Ltd.

Recommendation Target

Axis Direct

Q1FY18 profitability was impacted with consolidated EBITDAC margin down by 200 bps to 14% due to control on stent pricing, higher marketing spends by SRL and continued effects of demonetization.

Fortis Healthcare Ltd. has gained 30.17% in the last 3 Months

Is Fortis Healthcare Ltd. worth buying?

325 Votes:

Buy 77.54%

Sell 11.08%

Hold 11.38%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf